# Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis

> **NCT04571151** · PHASE4 · UNKNOWN · sponsor: **Skin Sciences, PLLC** · enrollment: 30 (estimated)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** LEXETTE 0.05% Topical Foam
- **DRUG:** Sorilux 0.005 % Topical Foam
- **OTHER:** Vehicle Foam

## Key facts

- **NCT ID:** NCT04571151
- **Lead sponsor:** Skin Sciences, PLLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01
- **Primary completion:** 2021-11
- **Final completion:** 2021-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04571151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04571151, "Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04571151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*